Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021Alize J Ferrari, Masayuki Teramoto, Robert Kaba Alhassan et al.|The Lancet|2024Cited by 4.4k
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021William M. Gardner, Rajaa Al‐Raddadi, Christian Razo et al.|The Lancet Haematology|2023Cited by 541
Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023Masayuki Teramoto, Mohammed Z. Allouh, Bright Opoku Ahinkorah et al.|The Lancet|2025Cited by 153
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019Dongze Wu, Ihsan Ullah Khan Altaf, Yingzhao Jin et al.|EClinicalMedicine|2023Cited by 132
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Salah Al Awaidy, Marissa B Reitsma et al.|The Lancet Public Health|2024Cited by 125